Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-25-014986
Filing Date
2025-03-26
Accepted
2025-03-26 16:38:00
Documents
4
Period of Report
2025-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1743021448.html 3  
1 FORM 3 wk-form3_1743021448.xml 3 1726
2 EX-24 exhibit24kvardapoa.htm EX-24 4435
3 exhibit24kvardapoa001.jpg GRAPHIC 247713
4 exhibit24kvardapoa002.jpg GRAPHIC 35053
  Complete submission text file 0001628280-25-014986.txt   397392
Mailing Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102
Business Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102 (650) 938-6300
23andMe Holding Co. (Issuer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE NEW YORK PLAZA NEW YORK NY 10004
Business Address
Kvarda Matthew (Reporting) CIK: 0001949448 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39587 | Film No.: 25773811